IN VIVO ENRICHMENT OF REGULATORY T CELLS BY BCL-2/BCL-XL INHIBITION PROMOTES TOLERANCE IN ALLOTRANSPLANTATION

IN VIVO ENRICHMENT OF REGULATORY T CELLS BY BCL-2/BCL-XL INHIBITION PROMOTES TOLERANCE IN ALLOTRANSPLANTATION

Detalles Bibliográficos
Autores principales:	Gabriel, S, Bon, N, Chen, J, Kraus, A, Bushell, A, Fehr, T, Cippa, P
Formato:	Journal article
Publicado:	2013

Ejemplares similares

Distinctive expression of Bcl-2 factors in regulatory T cells determines a pharmacological target to induce immunological tolerance
por: Sarah Sharon Gabriel, et al.
Publicado: (2016-03-01)

Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
por: Reut Yosef, et al.
Publicado: (2016-04-01)

MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
por: Mengyang Chang, et al.
Publicado: (2022-08-01)

A Caspase-Resistant Form of Bcl-XL, but Not Wild Type Bcl-XL, Promotes Clonogenic Survival After Ionizing Radiation
por: Alnawaz Rehemtulla, et al.
Publicado: (1999-04-01)

Bcl-XL inhibits membrane permeabilization by competing with Bax.
por: Lieven P Billen, et al.
Publicado: (2008-06-01)

Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics
por: D.S. Dalafave, et al.
Publicado: (2010-08-01)

Bcl-xL in neuroprotection and plasticity
por: Elizabeth Ann Jonas, et al.
Publicado: (2014-09-01)

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
por: Mike-Andrew Westhoff, et al.
Publicado: (2022-01-01)

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
por: Atenea A. Perez-Serna, et al.
Publicado: (2025-01-01)

Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
por: Yiru Zhang, et al.
Publicado: (2018-05-01)

Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
por: Enyuan Shang, et al.
Publicado: (2018-10-01)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Bassem Shebl, et al.
Publicado: (2022-09-01)

Killing of Sarcoma Cells by Proapoptotic Bcl-XS: Role of the BH3 Domain and Regulation by Bcl-XL
por: Raj. S. Mitra, et al.
Publicado: (2001-01-01)

Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.
por: Fariba Némati, et al.
Publicado: (2014-01-01)

Evaluation of bcl-2, bcl-xl and bax expression and apoptotic index in canine mammary tumours
por: YILDIRIM F, et al.
Publicado: (2014-07-01)

Bioactive Compounds from Penicillium sp. Inhibit Antiapoptotic Bcl-2, Bcl-XL and Mcl-1: An in silico Study
por: Adhie Massardi, et al.
Publicado: (2023-07-01)

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Issa, F, et al.
Publicado: (2019)

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Fadi Issa, et al.
Publicado: (2019-04-01)

GDNF Protects against Aluminum-Induced Apoptosis in Rabbits by Upregulating Bcl-2 and Bcl-XL and Inhibiting Mitochondrial Bax Translocation
por: Othman Ghribi, et al.
Publicado: (2001-10-01)

BCL-XL regulates the timing of mitotic apoptosis independently of BCL2 and MCL1 compensation
por: Chun Yin Yu, et al.
Publicado: (2024-01-01)

Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells
por: Ryan Kolb, et al.
Publicado: (2021-02-01)

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies
por: Katrine Melvold, et al.
Publicado: (2022-03-01)

Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
por: Ailsa Bennett, et al.
Publicado: (2016-01-01)

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer
por: Dimitrios E. Magouliotis, et al.
Publicado: (2022-11-01)

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and ApoptosisSummary
por: Kenji Ikezawa, et al.
Publicado: (2017-07-01)

Bcl-xL promotes metastasis independent of its anti-apoptotic activity
por: Soyoung Choi, et al.
Publicado: (2016-01-01)

Bcl-xL activity influences outcome of the mitotic arrest
por: M. Suleimenov, et al.
Publicado: (2022-09-01)

Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
por: Siti Fairus Abdul Rahman, et al.
Publicado: (2020-07-01)

BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
por: Longchuan Bai, et al.
Publicado: (2014-01-01)

Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
por: Digant Nayak, et al.
Publicado: (2024-03-01)

Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition
por: Trang Thi Thu Nguyen, et al.
Publicado: (2019-08-01)

UK-2A ANALOGUES: POTENTIAL INHIBITORS OF BCL-XL
por: , AMJ Putra, M Hanafi, Y Anita
Publicado: (2007)

Dynamics of Bcl-xL in water and membrane : molecular simulations
por: Maity, Atanu., et al.
Publicado: (2014)

Functions of BCL-XL at the Interface between Cell Death and Metabolism
por: Judith Michels, et al.
Publicado: (2013-01-01)

Dynamics of Bcl-xL in water and membrane: molecular simulations.
por: Atanu Maity, et al.
Publicado: (2013-01-01)

Molecular interaction of tumor suppressor protein p53 and anti-apoptotic proteins Bcl-2 and Bcl-XL.
por: Yoon, Ho Sup.
Publicado: (2010)

ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
por: Li Ji-Yu, et al.
Publicado: (2012-12-01)

Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing <it>bcl-xl</it>, <it>bcl-2</it>, and <it>mcl-1</it>
por: Mena Salvador, et al.
Publicado: (2012-01-01)

P409: BCL-2/BCL-XL INHIBITION INDUCES APOPTOSIS AND CIRCUMVENTS VENETOCLAX RESISTANCE IN TP53-MUTATED ACUTE MYELOID LEUKEMIA
por: Ida Vänttinen, et al.
Publicado: (2023-08-01)

ΔN-Bcl-xL, a therapeutic target for neuroprotection
por: Han-A Park, et al.
Publicado: (2017-01-01)